Navigation Links
Bradmer announces 2008 first quarter operational and financial results
Date:5/9/2008

tients, which it expects to commence in the spring of 2008. During the time leading up to opening the trial for enrollment, Bradmer intends to execute on the following components of its operational plan:

- Continue the activation and training of glioblastoma multiforme

treatment centers across the U.S.

- Submit final clinical documentation to the FDA, upon completion of

their review of the manufacturing data already submitted.

- Ship initial drug quantities to clinical trial sites.

Additional information about the Company, including the MD&A and financial results may be found on SEDAR at http://www.sedar.com.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. To date, over US$60 million in grants and related support has driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results and has completed Phase II clinical trials at Duke University. Bradmer is currently in the process of organizing a pivotal multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Bradmer announces new additions to management team
2. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
3. Notice of Bradmer Pharmaceuticals Conference Call
4. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
5. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
6. Bradmer announces additions to Scientific Advisory Board
7. Bradmer Medical Isotope Supply For Phase III Trial Secure
8. Bradmer to present at Rodman & Renshaw Healthcare Conference
9. Bradmer provides Phase III Neuradiab trial update and guidance
10. Bradmer announces management changes
11. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard to ... & Day Spa in Santa Barbara, CA is offering the solution by offering ... permanently eliminates sweat and odor glands in the underarms. This simple and permanent ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... Local Food,” scheduled for Nov. 3 – 4, 2015, at UC San Diego, ... create new businesses, improve food access, and manage resources efficiently against the dueling ...
(Date:8/4/2015)... ... , ... Members receiving care from a doctor who participates in a patient-centered ... nine percent lower -- than those members at traditional doctor practices, according to the ... , “The promise of patient-centered, or value-based, care to deliver better quality care at ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... “Dr. Google” before calling a physician. In an effort to share more and ... care provider in Pennsylvania to publicly share patient satisfaction ratings and comments about ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are invited to take ... world renowned Beverly Hills facelift surgeon , Dr. Paul Nassif. The opportunity ... individuals to achieve an outer appearance that meets their personal goals. This consultation ...
Breaking Medicine News(10 mins):Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
... to detect dementia so that it can be used ... test called National Institute //of Ageing's Consortium to Establish ... only ten minutes to administer. ,Researchers had focused ... stages often go undetected. They used a standardized diagnostic ...
... known that HIV patients are at an increased risk of ... shows // aggressive antiretroviral therapy may help lower that risk. ... therapy was associated with a lower incidence of Kaposi sarcoma ... more than 7,300 patients infected with HIV and the data ...
... reduction in inflammation can be achieved by a diet high ... such as salmon or mackerel. This is supported by the ... from an essential fatty acid in fish oil. ... fatty acids. Eating fatty fish is beneficial to patients with ...
... in the building behind me, starving to death, " Mark ... we smile together, and we talk together. She is my ... ,Members of the US Congress said on Saturday that ... at saving the life of Terri Schiavo, the brain damaged ...
... the drug rasagiline to standard treatment with levodopa can ... spend suffering from motor fluctuations they experience during the ... oral rasagiline to the drug entacapone, which must be ... around 690 patients. Both of the additional drugs were ...
... which examined the tobacco byproducts in the urine samples ... // themselves by thinking that they are getting fewer ... ,No significant difference was found in the amount ... the type of cigarettes they smoked nor there was ...
Cached Medicine News:
(Date:8/4/2015)... , Aug. 4, 2015  The Pittsburgh Life ... investment firm, announced today that one of its portfolio ... sell their Flex ® Robotic System in the ... or more proud of Medrobotics," said John W. ... come a very long way since spinning out of ...
(Date:8/4/2015)... SAN FRANCISCO , Aug. 4, 2015 /PRNewswire/ ... Nicki Vasquez , Ph.D., as vice president ... have a leadership role in the management of ... cancer therapeutics pipeline, including antibody-drug conjugates, bispecific antibodies ... Dr. Vasquez brings more than 22 years of ...
(Date:8/4/2015)... Aug. 4, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Transdermal ... to their offering. ... - an approach used to deliver drugs ... an alternative to oral,intravascular, subcutaneous and transmucosal ...
Breaking Medicine Technology:Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... demand for medical devices,has been increasing in recent ... is so high because local manufacturers concentrate mainly ... in most,Russian hospitals and clinics are obsolete and ... attractive also for foreign manufacturers. , ...
... FORD, Pa., Jan. 29 Endo Pharmaceuticals (Nasdaq: ... it has concluded its research collaboration with Alexza Pharmaceuticals, ... inhaled fentanyl product for the treatment of breakthrough pain ... fentanyl (AZ-003/EN-3284), has completed Phase I clinical testing and ...
Cached Medicine Technology:Foreign Medical Devices are in High Demand in Russia 2Foreign Medical Devices are in High Demand in Russia 3Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 2Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 3
... typhi rapid test is a qualitative ... employs a conation of monoclonal,antibody/colloidal gold ... immobilized on the solid phase. This ... Salmonella typhi (typhoid) infection with a ...
... an immunochromatographic in vitro assay,for detection ... infection.,Infectious mononucleosis (IM) is caused by ... is based on detection of,serum antibodies ... the,heterophile antibodies present in the sera ...
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
... Insta Test is an immunochromatography ... It is designed for qualitative ... specimens. The presence of myoglobin ... or higher can be detected ...
Medicine Products: